DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
FDA Approves (18)F-DCFPyL PET Agent in Prostate Cancer.
J Nucl Med 2021;
62 (08) 11N
Access:
We do not assume any responsibility for the contents of the web pages of other providers.